Adjuvant whole abdominal radiotherapy in epithelial cancer of the ovary

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 360-365

  Hepp, Rodrigo ^a   Baeza, Mario R ^a,c   Olfos, Patricio ^a   Suarez, Eugenio ^b  

^a Instituto de Radiomedicina Santiago   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^c Department of Radiation Oncology ^*  (Chile)

Author keywords

Ovarian cancer; Radiotherapy; Whole abdominal irradiation

Indexed keywords

CHEMOTHERAPY; DISEASES; IRRADIATION; PATIENT TREATMENT; STATISTICAL METHODS; SURGERY; TOXICITY; TUMORS;

LINEAR ACCELERATOR;

RADIOTHERAPY;

PLATINUM;

ABDOMINAL RADIOTHERAPY; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CADAVER; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; HUMAN; INTESTINE OBSTRUCTION; IRRADIATION; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PELVIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; STATISTICAL ANALYSIS; TIME; TOXICITY; VOMITING;

ABDOMEN; ADOLESCENT; ADULT; AGED; DIARRHEA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SECOND-LOOK SURGERY; SURVIVAL RATE;

EID: 0036603587     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02728-1     Document Type: Article

References (36)

1. Age adjusted cancer death rates 1930-1997
2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
3. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
4. Randomised trial of paclitaxel (PTX) and carboplatin (CBDCA) versus a control arm of carboplatin or CAP (cyclophosphamide, doxorubicin & cisplatin): The third International Collaborative Ovarian neoplasm study (ICON3)
5. Ovarian carcinoma: Improved survival following abdominopelvic irradiation in patients with a complete pelvic operation
6. Early stage ovarian cancer: A randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate - A National Cancer Institute of Canada Clinical Trials Group report
7. Randomized study of whole abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer
8. High-risk early stage ovarian cancer: Randomized trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy
9. Radiation dose response for subclinical metastases
10. Choice of postoperative therapy based on prognostic factors
11. Carcinoma of the ovary: Annual report on the results of treatment of gynaecological cancer, 23rd vol
12. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
13. Nonparametric estimation from incomplete observations
14. Statistical aspects of the analysis of the data from retrospective studies of disease
15. Postoperative treatment of early cancer of the ovary: A random trial between postoperative irradiation and chemotherapy
16. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma
17. High-dose therapy for ovarian carcinoma
18. Radiotherapeutic management of ovarian cancer
19. Postoperative abdominopelvic radiation therapy for ovarian cancer
20. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdominal irradiation (WAR)
21. Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: A 15 year review
22. Primary adjuvant abdominal irradiation in ovarian carcinoma
23. Abdominopelvic radiotherapy in ovarian cancer: A 10 year experience
24. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer
25. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: A North Thames Ovary Group study
26. Integrating radiation therapy into the management of ovarian cancer
27. Survival and prognostic factors of early ovarian cancer
28. The accuracy of staging: An important prognostic determinator in Stage I ovarian carcinoma - A multivariate analysis
29. A randomized clinical trial of moving strip versus open field whole abdominal irradiation in patients with invasive epithelial cancer of the ovary
30. A randomized study of two doses of abdominopelvic radiation therapy for patient with optimally debulked stage I, II and III ovarian cancer
31. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: Results of a Gynecol Oncol Group study